Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes. - Wikidata - awgldk - TriplyDB

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes.

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes.

http://www.wikidata.org/entity/Q33962626

about

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes.

http://www.wikidata.org/entity/Q33962626

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@ast

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@en

type

label

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@ast

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@en

prefLabel

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@ast

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@en

P1433

Q33962626-9469873C-DAF1-43FE-ADDA-BE1FCD27DF62

P1476

Q33962626-8CC0BAB2-1161-4FFD-B1AD-1478EDC2DAED

P2093

Q33962626-01C0B803-9591-4FA2-8A37-3329C95AB7B2

Q33962626-7C0F898B-D5B0-4239-AB19-C34810F74E57

Q33962626-CFD5EA0A-AF2A-4971-97E8-29605164332B

Q33962626-E7549DBB-A9C2-4F3E-8A40-4DBCD8570DFA

Q33962626-FE7DEF02-85D1-4EAD-806D-37A9D3CFEF57

P2860

Q33962626-0051EF23-0709-4A25-B3C1-3B2458BCAD58

Q33962626-02915EFC-BF51-4C3F-B06B-77F9C49B0252

Q33962626-0809FE7E-6345-418F-A58A-30A75E850177

Q33962626-1101939D-D55B-4307-B357-3E25534457CB

Q33962626-116B7E1E-022C-41FB-96C6-60DF96C88E23

Q33962626-17F935B4-C1D0-4185-B675-DCD4B69F6801

Q33962626-1B6322AA-A4F6-4BBF-A158-8DA767CAECD1

Q33962626-2B817026-4E37-46DF-A031-3D32159B0305

Q33962626-2BE75456-A931-494C-81AB-103CE83314DB

Q33962626-2CFC5687-6899-4389-B3FB-49FFA3598CA8

P304

Q33962626-E5C42040-D40D-4CD6-BB4B-7AFE9E206F8A

P31

Q33962626-D07F88AC-794A-4A8F-A3E6-5950843BF6F3

P356

Q33962626-01C5A811-C3BC-4D6F-9E76-3946D2398D31

P433

Q33962626-13F10340-E3CF-44F8-AC70-6E4110E86C0C

P478

Q33962626-7D148E77-5071-4BB9-80BD-2114A2D90C6E

P577

Q33962626-E121062D-2E06-4FA6-A757-129BA7C02CC5

P5875

Q33962626-DA0A6328-EAC4-4CA0-8BC8-A29DCDB9D339

P698

Q33962626-2FA96196-8DF2-4D63-991A-E774A15D6052

P921

Q33962626-0E438141-5A30-4616-9E02-4F6F3AA36352

P932

Q33962626-A4639B14-B51F-4ED0-B7FD-DAC09A1C31FF

P356

P1433

Experimental and Therapeutic Medicine

P1476

Associations between apolipopr ...... lbuminuria in type 2 diabetes.

@en

P2093

Bing Liu

http://www.w3.org/2001/XMLSchema#string

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Guang-Yao Song

http://www.w3.org/2001/XMLSchema#string

Lu-Ping Ren

http://www.w3.org/2001/XMLSchema#string

Zhi-Juan Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.

Lipoprotein abnormalities in diabetic nephropathy.

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.

A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.

P304

951-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2014.1830

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264793229

http://www.w3.org/2001/XMLSchema#string

P698

25120629

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4113638

http://www.w3.org/2001/XMLSchema#string